DESVENLAFAXINE

Generic: DESVENLAFAXINE

Sun Pharmaceutical IndustriesManufacturer
ORALRoute
DESVENLAFAXINEActive Substance
2013-03-04Original Approval

DESVENLAFAXINE is FDA application NDA204150, sponsored by ALEMBIC PHARMS LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Class II2021-03-15
Desvenlafaxine Extended-Release Tablets 25 mg 30 Tablets Rx Only NDC 0591-4060-30 Manufactured by: Actavis Laboratories

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Top Reported Reactions

1
DRUG INEFFECTIVE
708 reports
2
OFF LABEL USE
356 reports
3
NAUSEA
336 reports
4
HEADACHE
294 reports
5
ANXIETY
288 reports
6
TOXICITY TO VARIOUS AGENTS
287 reports
7
FATIGUE
276 reports
8
DEPRESSION
240 reports
9
DIZZINESS
226 reports
10
COMPLETED SUICIDE
212 reports